Intracarotid cisplatin chemotherapy for recurrent gliomas

M. S. Mahaley, S. W. Hipp, Edward Dropcho, L. Bertsch, S. Cush, T. Tirey, G. Y. Gillespie

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Forty patients with recurrent gliomas were treated with monthly intra-arterial infusions of cisplatin. Of the 35 evaluable patients, 12 (34%) responded with computerized tomography (CT) evidence of a decrease in tumor size; in 14 (40%) the tumor stabilized on CT scans, and in nine (26%) the disease progessed. The median survival period was 35.0 weeks for the responders and 27.5 weeks for all 35 patients. The primary toxicities were renal (reversible alterations in creatinine clearance), otological (severe hearing loss in one patient), and likely neurotoxicity in one patient who had received bilateral infusions following contralateral tumor progression. The authors are now using this form of regional chemotherapy sequentially before and following radiotherapy in newly diagnosed cases.

Original languageEnglish (US)
Pages (from-to)371-378
Number of pages8
JournalJournal of Neurosurgery
Volume70
Issue number3
StatePublished - 1989
Externally publishedYes

Fingerprint

Glioma
Cisplatin
Drug Therapy
Tomography
Intra Arterial Infusions
Neoplasms
Hearing Loss
Creatinine
Radiotherapy
Kidney
Survival

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Mahaley, M. S., Hipp, S. W., Dropcho, E., Bertsch, L., Cush, S., Tirey, T., & Gillespie, G. Y. (1989). Intracarotid cisplatin chemotherapy for recurrent gliomas. Journal of Neurosurgery, 70(3), 371-378.

Intracarotid cisplatin chemotherapy for recurrent gliomas. / Mahaley, M. S.; Hipp, S. W.; Dropcho, Edward; Bertsch, L.; Cush, S.; Tirey, T.; Gillespie, G. Y.

In: Journal of Neurosurgery, Vol. 70, No. 3, 1989, p. 371-378.

Research output: Contribution to journalArticle

Mahaley, MS, Hipp, SW, Dropcho, E, Bertsch, L, Cush, S, Tirey, T & Gillespie, GY 1989, 'Intracarotid cisplatin chemotherapy for recurrent gliomas', Journal of Neurosurgery, vol. 70, no. 3, pp. 371-378.
Mahaley MS, Hipp SW, Dropcho E, Bertsch L, Cush S, Tirey T et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. Journal of Neurosurgery. 1989;70(3):371-378.
Mahaley, M. S. ; Hipp, S. W. ; Dropcho, Edward ; Bertsch, L. ; Cush, S. ; Tirey, T. ; Gillespie, G. Y. / Intracarotid cisplatin chemotherapy for recurrent gliomas. In: Journal of Neurosurgery. 1989 ; Vol. 70, No. 3. pp. 371-378.
@article{33a1ff0545f74dceae033f59c3f04d06,
title = "Intracarotid cisplatin chemotherapy for recurrent gliomas",
abstract = "Forty patients with recurrent gliomas were treated with monthly intra-arterial infusions of cisplatin. Of the 35 evaluable patients, 12 (34{\%}) responded with computerized tomography (CT) evidence of a decrease in tumor size; in 14 (40{\%}) the tumor stabilized on CT scans, and in nine (26{\%}) the disease progessed. The median survival period was 35.0 weeks for the responders and 27.5 weeks for all 35 patients. The primary toxicities were renal (reversible alterations in creatinine clearance), otological (severe hearing loss in one patient), and likely neurotoxicity in one patient who had received bilateral infusions following contralateral tumor progression. The authors are now using this form of regional chemotherapy sequentially before and following radiotherapy in newly diagnosed cases.",
author = "Mahaley, {M. S.} and Hipp, {S. W.} and Edward Dropcho and L. Bertsch and S. Cush and T. Tirey and Gillespie, {G. Y.}",
year = "1989",
language = "English (US)",
volume = "70",
pages = "371--378",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Intracarotid cisplatin chemotherapy for recurrent gliomas

AU - Mahaley, M. S.

AU - Hipp, S. W.

AU - Dropcho, Edward

AU - Bertsch, L.

AU - Cush, S.

AU - Tirey, T.

AU - Gillespie, G. Y.

PY - 1989

Y1 - 1989

N2 - Forty patients with recurrent gliomas were treated with monthly intra-arterial infusions of cisplatin. Of the 35 evaluable patients, 12 (34%) responded with computerized tomography (CT) evidence of a decrease in tumor size; in 14 (40%) the tumor stabilized on CT scans, and in nine (26%) the disease progessed. The median survival period was 35.0 weeks for the responders and 27.5 weeks for all 35 patients. The primary toxicities were renal (reversible alterations in creatinine clearance), otological (severe hearing loss in one patient), and likely neurotoxicity in one patient who had received bilateral infusions following contralateral tumor progression. The authors are now using this form of regional chemotherapy sequentially before and following radiotherapy in newly diagnosed cases.

AB - Forty patients with recurrent gliomas were treated with monthly intra-arterial infusions of cisplatin. Of the 35 evaluable patients, 12 (34%) responded with computerized tomography (CT) evidence of a decrease in tumor size; in 14 (40%) the tumor stabilized on CT scans, and in nine (26%) the disease progessed. The median survival period was 35.0 weeks for the responders and 27.5 weeks for all 35 patients. The primary toxicities were renal (reversible alterations in creatinine clearance), otological (severe hearing loss in one patient), and likely neurotoxicity in one patient who had received bilateral infusions following contralateral tumor progression. The authors are now using this form of regional chemotherapy sequentially before and following radiotherapy in newly diagnosed cases.

UR - http://www.scopus.com/inward/record.url?scp=0024593592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024593592&partnerID=8YFLogxK

M3 - Article

C2 - 2536804

AN - SCOPUS:0024593592

VL - 70

SP - 371

EP - 378

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -